The Role of Mitophagy in Glaucomatous Neurodegeneration

Author:

Stavropoulos Dimitrios12,Grewal Manjot K.34,Petriti Bledi35,Chau Kai-Yin5ORCID,Hammond Christopher J.67,Garway-Heath David F.3ORCID,Lascaratos Gerassimos16ORCID

Affiliation:

1. Department of Ophthalmology, King’s College Hospital, London SE5 9RS, UK

2. Department of Ophthalmology, 417 Veterans Army Hospital (NIMTS), 11521 Athens, Greece

3. NIHR Biomedical Research Center, Moorfields Eye Hospital and UCL Institute of Ophthalmology, London EC1V 9EL, UK

4. Division of Optometry and Visual Science, School of Health Sciences, City, University of London, London EC1V 0HB, UK

5. Department of Clinical & Movement Neurosciences, UCL Queens Square Institute of Neurology, London NW3 2PF, UK

6. Section of Ophthalmology, School of Life Course Sciences, King’s College London, London SE1 7EH, UK

7. Department of Ophthalmology, St Thomas’ Hospital, London SE1 7EH, UK

Abstract

This review aims to provide a better understanding of the emerging role of mitophagy in glaucomatous neurodegeneration, which is the primary cause of irreversible blindness worldwide. Increasing evidence from genetic and other experimental studies suggests that mitophagy-related genes are implicated in the pathogenesis of glaucoma in various populations. The association between polymorphisms in these genes and increased risk of glaucoma is presented. Reduction in intraocular pressure (IOP) is currently the only modifiable risk factor for glaucoma, while clinical trials highlight the inadequacy of IOP-lowering therapeutic approaches to prevent sight loss in many glaucoma patients. Mitochondrial dysfunction is thought to increase the susceptibility of retinal ganglion cells (RGCs) to other risk factors and is implicated in glaucomatous degeneration. Mitophagy holds a vital role in mitochondrial quality control processes, and the current review explores the mitophagy-related pathways which may be linked to glaucoma and their therapeutic potential.

Publisher

MDPI AG

Subject

General Medicine

Reference249 articles.

1. GBD 2019 Blindness and Vision Impairment Collaborators, and Vision Loss Expert Group of the Global Burden of Disease Study (2021). Causes of Blindness and Vision Impairment in 2020 and Trends over 30 Years, and Prevalence of Avoidable Blindness in Relation to VISION 2020: The Right to Sight: An Analysis for the Global Burden of Disease Study. Lancet Glob. Health, 9, e144–e160.

2. Leading Causes of Certifiable Visual Loss in England and Wales during the Year Ending 31 March 2013;Quartilho;Eye,2016

3. Glaucoma;Kang;Med. Clin. N. Am.,2021

4. Chronic Human Glaucoma Causing Selectively Greater Loss of Large Optic Nerve Fibers;Quigley;Ophthalmology,1988

5. Glaucomatous Optic Neuropathy: Mitochondrial Dynamics, Dysfunction and Protection in Retinal Ganglion Cells;Ju;Prog. Retin. Eye Res.,2022

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3